Predicting Persistent Postconcussive Problems in Pediatrics (5P)

Sponsor
Children's Hospital of Eastern Ontario (Other)
Overall Status
Completed
CT.gov ID
NCT01873287
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
3,063
9
22
340.3
15.5

Study Details

Study Description

Brief Summary

Concussion, a mild traumatic injury common in children and adolescents, is a complex pathophysiological process affecting the brain. The lay press is inundated with reports of tragic consequences of concussion, and children are not immune.

Persistent postconcussive symptoms (PCS) is defined as the persistence of somatic, cognitive, physical, psychological or behavioural changes lasting more than one month following injury. PCS significantly impacts children and their family's quality of life through school absenteeism, depressed mood and loss of activities.

Validated, easy-to-use prognosticators do not exist for clinicians to identify children at highest risk for PCS. As a result,physicians cannot accurately inform children and parents whether they should expect longer symptoms, nor initiate pharmacotherapy or other management to reduce the occurrence or severity of PCS.

The investigators objective is to derive and validate a clinical prediction rule for the development of PCS in children and adolescents presenting to the emergency department (ED) following acute head injury. The investigators have three aims: (1) determine PCS incidence at one-month follow-up in children aged 5-17 who sustain a concussion; (2) derive a rule to predict PCS from variables present in the history and physical examination; and, (3) assess the accuracy, reliability and acceptability of the prediction rule in a subsequent cohort. Using a prospective, multicentre study at nine large Canadian pediatric EDs, the investigators will recruit the largest prospective epidemiological cohort of children with concussions in the literature.

This work will provide rigorous evidence to determine PCS incidence in children and its impact on quality of life. The results will enable clinicians to identify children at highest risk for PCS, optimize treatment and provide families with realistic anticipatory guidance. This study will also establish a strong and vital evidence base to advance concussion research.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The full protocol has been published in BMJ Open (open access):

    Zemek R, Osmond MH, Barrowman N for PERC Concussion Team. Predicting and preventing postconcussive problems in paediatrics (5P) study: protocol for a prospective multicentre clinical prediction rule derivation study in children with concussion. BMJ Open. 2013 Aug 1;3(8). pii:e003550. doi: 10.1136/bmjopen-2013-003550. PubMed PMID: 23906960. https://www.ncbi.nlm.nih.gov/pubmed/23906960

    The primary outcome results have been published in JAMA (open access):

    Zemek R, Barrowman N, Freedman SB, Gravel J, Gagnon I, McGahern C, Aglipay M, Sangha G, Boutis K, Beer D, Craig W, Burns E, Farion KJ, Mikrogianakis A, Barlow K, Dubrovsky AS, Meeuwisse W, Gioia G, Meehan WP 3rd, Beauchamp MH, Kamil Y, Grool AM, Hoshizaki B, Anderson P, Brooks BL, Yeates KO, Vassilyadi M, Klassen T, Keightley M, Richer L, DeMatteo C, Osmond MH; Pediatric Emergency Research Canada (PERC) Concussion Team. Clinical Risk Score for Persistent Postconcussion Symptoms among Children With Acute Concussion in the ED. JAMA. 2016 Mar 8;315(10):1014-25. doi: 10.1001/jama.2016.1203. PubMed PMID: 26954410. http://dx.doi.org/10.1001/jama.2016.1203

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    3063 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Predicting Persistent Postconcussive Problems in Pediatrics: A Clinical Prediction Rule Derivation and Validation Study
    Study Start Date :
    Aug 1, 2013
    Actual Primary Completion Date :
    Jun 1, 2015
    Actual Study Completion Date :
    Jun 1, 2015

    Outcome Measures

    Primary Outcome Measures

    1. Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up. [1 month]

      The primary outcome is the number of of children aged 5 - 17 years who have PCS at one-month follow-up. A PCS case is defined as an increase from pre-concussion baseline of three or more symptoms on the validated PCSI at one-month (consistent with the ICD-10 definition of PCS).

    Secondary Outcome Measures

    1. Pediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injury [1 month]

      The PedsQL™ is a reliable and valid measure of health-related quality of life in healthy children and adolescents and those with acute and/or chronic health conditions. Parent versions exist for children aged 2 to 18 years (in 4 age groups) and child versions for those aged 5 and over. The inventory covers four domains: physical, emotional, social and school. Items are calculated and transformed into an overall score with a range of 0 to 100 points, with more points indicating better quality of life. This secondary outcome measure will be used to determine the impact of PCS on quality of life on patients and families.

    2. Neuropsychological Evaluation [1 month and 3 month]

      A separate battery of neuropsychological assessment measures will be administered to those children who choose to participate in this arm of the study. This battery includes measures of intelligence, language, visual-spatial/motor functions, attention, memory/working memory, executive functioning, academic achievement, as well as behavioural/socioemotional functioning.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Subjects presenting to one of the study hospital EDs after sustaining a head injury will be eligible if they:

    • are aged 5 to 17 years;

    • have a concussion, defined by Zurich consensus statement;22

    • suffered the initial injury in the previous 48 hours;

    • are proficient in English or French.

    Exclusion Criteria: Patients will be excluded if they present with traumatic head injuries with any of the following:

    • GCS ≤13; any abnormality on standard neuroimaging studies, including any positive head CT findings (Note: neuroimaging is not required, but may be performed by the clinician if thought to be clinically indicated);

    • neurosurgical operative intervention, intubation or PICU care required;

    • multi-system injuries with treatment requiring admission to hospital, operating room or procedural sedation in the ED (Note: admission to hospital for observation or management of ongoing concussion symptoms is not an exclusion criteria);

    • severe chronic neurological developmental delay resulting in communication difficulties;

    • intoxication at the time of ED presentation as per clinician judgment;

    • no clear history of trauma as primary event (e.g., seizure, syncope or migraine as primary event);

    • previously enrolled in this same study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Stollery Children's Hospital Edmonton Alberta Canada
    2 Children's Hospital of Winnipeg Winnipeg Manitoba Canada
    3 IWK Health Sciences Centre Halifax Nova Scotia Canada
    4 Alberta Children's Hospital Calgary Ontario Canada
    5 Children's Hospital of Western Ontario London Ontario Canada
    6 Children's Hospital of Eastern Ontario Ottawa Ontario Canada K1H 8L1
    7 The Hospital for Sick Children Toronto Ontario Canada
    8 CHU Sainte-Justine Montreal Quebec Canada
    9 Montreal Children's Hospital Montreal Quebec Canada

    Sponsors and Collaborators

    • Children's Hospital of Eastern Ontario
    • Canadian Institutes of Health Research (CIHR)

    Investigators

    • Principal Investigator: Roger L Zemek, MD, CHEO

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Roger Zemek, Pediatric Emergentologist, Division of Emergency Medicine, Children's Hospital of Eastern Ontario
    ClinicalTrials.gov Identifier:
    NCT01873287
    Other Study ID Numbers:
    • CIHR-302955, CIHR-287347
    First Posted:
    Jun 10, 2013
    Last Update Posted:
    Nov 18, 2019
    Last Verified:
    Oct 1, 2019
    Keywords provided by Roger Zemek, Pediatric Emergentologist, Division of Emergency Medicine, Children's Hospital of Eastern Ontario

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Derivation Arm Validation Arm
    Arm/Group Description Inclusion criteria. Subjects presenting to one of the study hospital EDs after sustaining a head injury will be eligible if they: (1) are aged 5 to 17 years; (2) have a concussion, defined by Zurich consensus statement; (3) suffered the initial injury in the previous 48 hours; (4) are proficient in English or French. Exclusion criteria. Patients will be excluded if they present with traumatic head injuries with any of the following: GCS ≤13; any abnormality on standard neuroimaging studies,; neurosurgical operative intervention, intubation or PICU care required; multi-system injuries with treatment requiring admission to hospital, operating room or procedural sedation in the ED; severe chronic neurological developmental delay resulting in communication difficulties; intoxication at the time of ED presentation as per clinician judgment; no clear history of trauma as primary event (e.g., seizure, syncope or migraine as primary event); previously enrolled in this same study. Inclusion criteria. Subjects presenting to one of the study hospital EDs after sustaining a head injury will be eligible if they: (1) are aged 5 to 17 years; (2) have a concussion, defined by Zurich consensus statement; (3) suffered the initial injury in the previous 48 hours; (4) are proficient in English or French. Exclusion criteria. Patients will be excluded if they present with traumatic head injuries with any of the following: GCS ≤13; any abnormality on standard neuroimaging studies,; neurosurgical operative intervention, intubation or PICU care required; multi-system injuries with treatment requiring admission to hospital, operating room or procedural sedation in the ED; severe chronic neurological developmental delay resulting in communication difficulties; intoxication at the time of ED presentation as per clinician judgment; no clear history of trauma as primary event (e.g., seizure, syncope or migraine as primary event); previously enrolled in this same study.
    Period Title: Overall Study
    STARTED 2006 1057
    COMPLETED 1701 883
    NOT COMPLETED 305 174

    Baseline Characteristics

    Arm/Group Title Derivation Cohort Validation Cohort Total
    Arm/Group Description Total of all reporting groups
    Overall Participants 2006 1057 3063
    Age (years) [Median (Inter-Quartile Range) ]
    Median (Inter-Quartile Range) [years]
    11.8
    12.3
    12.0
    Sex: Female, Male (Count of Participants)
    Female
    765
    38.1%
    440
    41.6%
    1205
    39.3%
    Male
    1241
    61.9%
    617
    58.4%
    1858
    60.7%
    Region of Enrollment (participants) [Number]
    Canada
    2006
    100%
    1057
    100%
    3063
    100%

    Outcome Measures

    1. Primary Outcome
    Title Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.
    Description The primary outcome is the number of of children aged 5 - 17 years who have PCS at one-month follow-up. A PCS case is defined as an increase from pre-concussion baseline of three or more symptoms on the validated PCSI at one-month (consistent with the ICD-10 definition of PCS).
    Time Frame 1 month

    Outcome Measure Data

    Analysis Population Description
    Completed 1-month followup.
    Arm/Group Title PPCS in Derivation PPCS in Validation
    Arm/Group Description August 2013 to September 2014 October 2014 to June 2015
    Measure Participants 1701 883
    Count of Participants [Participants]
    510
    25.4%
    291
    27.5%
    2. Secondary Outcome
    Title Pediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injury
    Description The PedsQL™ is a reliable and valid measure of health-related quality of life in healthy children and adolescents and those with acute and/or chronic health conditions. Parent versions exist for children aged 2 to 18 years (in 4 age groups) and child versions for those aged 5 and over. The inventory covers four domains: physical, emotional, social and school. Items are calculated and transformed into an overall score with a range of 0 to 100 points, with more points indicating better quality of life. This secondary outcome measure will be used to determine the impact of PCS on quality of life on patients and families.
    Time Frame 1 month

    Outcome Measure Data

    Analysis Population Description
    Completed PedsQL at 1-month post-concussion.
    Arm/Group Title Participants With PPCS Participants Without PPCS
    Arm/Group Description The primary outcome measure, PPCS, was defined in keeping with the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) definition of postconcussion syndrome, which requires persistence beyond 4 weeks of at least 3 symptoms compared with state of being prior to the injury. In the study, an individual symptom was defined as a positive difference between the patient-reported current minus the perceived preinjury symptom rating on PCSI; both were completed 28 days after the injury. Less than 3 symptoms compared with state of being prior to the injury at 28 days. In the study, an individual symptom was defined as a positive difference between the patient-reported current minus the perceived preinjury symptom rating on PCSI; both were completed 28 days after the injury.
    Measure Participants 510 1157
    Mean (95% Confidence Interval) [units on a scale]
    70.0
    80.3
    3. Secondary Outcome
    Title Neuropsychological Evaluation
    Description A separate battery of neuropsychological assessment measures will be administered to those children who choose to participate in this arm of the study. This battery includes measures of intelligence, language, visual-spatial/motor functions, attention, memory/working memory, executive functioning, academic achievement, as well as behavioural/socioemotional functioning.
    Time Frame 1 month and 3 month

    Outcome Measure Data

    Analysis Population Description
    Participants assessed at 4- and 12-weeks post-injury using direct, standardized measures of intellectual functioning, verbal memory, executive functioning, attention/working memory, processing speed and fine motor abilities.
    Arm/Group Title Number of Children With Neuropsychological Impairment
    Arm/Group Description Incidence of neuropsychological impairment was determined using the Neuropsychological Impairment (NPI) rule (Beauchamp et al., 2015) and multiple hierarchical logistic and linear regressions were performed to assess the contribution of pre-morbid factors, acute symptoms, and acute cognitive testing to neuropsychological impairment and performance.
    Measure Participants 311
    Count of Participants [Participants]
    32
    1.6%

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Participants
    Arm/Group Description All enrolled participants.
    All Cause Mortality
    Participants
    Affected / at Risk (%) # Events
    Total 0/3063 (0%)
    Serious Adverse Events
    Participants
    Affected / at Risk (%) # Events
    Total 0/3063 (0%)
    Other (Not Including Serious) Adverse Events
    Participants
    Affected / at Risk (%) # Events
    Total 0/3063 (0%)

    Limitations/Caveats

    Selection bias (children presenting to ED as compared to general primary care) may limit generalizability. There is no control group (e.g., orthopedic injury) to compare symptom scores. Socio-economic status and race data were not collected.

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Roger Zemek
    Organization Children's Hospital of Eastern Ontario
    Phone 613-737-7600
    Email rzemek@cheo.on.ca
    Responsible Party:
    Roger Zemek, Pediatric Emergentologist, Division of Emergency Medicine, Children's Hospital of Eastern Ontario
    ClinicalTrials.gov Identifier:
    NCT01873287
    Other Study ID Numbers:
    • CIHR-302955, CIHR-287347
    First Posted:
    Jun 10, 2013
    Last Update Posted:
    Nov 18, 2019
    Last Verified:
    Oct 1, 2019